Blood Testing Market to Surpass US$ 249.7 Billion by 2035, Fueled by AI-Driven Diagnostics, Point-of-Care Testing, and Rising Chronic Disease Burden | Latest Report TMR

The global blood testing market is witnessing robust growth as healthcare providers increasingly rely on blood-based diagnostics for disease detection, monitoring, and preventive care. Blood testing remains one of the most widely used diagnostic tools for evaluating overall health, identifying chronic and infectious diseases, assessing organ function, and monitoring treatment outcomes. Routine blood tests are an integral part of annual health checkups and play a vital role in early diagnosis, enabling timely medical intervention and improved patient outcomes.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2517

The market is evolving rapidly with the adoption of innovative technologies such as point-of-care (POC) testing, automated analyzers, artificial intelligence (AI), lab-on-a-chip systems, and molecular diagnostics. These advancements are improving testing accuracy, reducing turnaround time, and making diagnostic services more accessible in hospitals, diagnostic laboratories, and home healthcare settings.

Market Overview

The global blood testing market was valued at US$ 104.4 Bn in 2024 and is expected to expand at a CAGR of 8.2% from 2025 to 2035, surpassing US$ 249.7 Bn by the end of 2035. The market's growth is fueled by the increasing prevalence of chronic diseases, growing awareness of preventive healthcare, and continuous technological innovation.

Healthcare systems worldwide are emphasizing early disease detection to reduce treatment costs and improve patient outcomes. Blood testing supports this objective by enabling accurate diagnosis of conditions such as diabetes, cardiovascular disorders, cancer, infectious diseases, and hormonal imbalances. Additionally, increasing healthcare expenditure and the expanding elderly population are further strengthening market demand.

Key Drivers of Market Growth

The rising prevalence of chronic diseases remains the primary growth driver for the blood testing market. Conditions including diabetes, cancer, cardiovascular diseases, and kidney disorders require continuous monitoring through routine blood tests. According to recent health estimates, millions of new cancer cases and diabetes diagnoses continue to emerge annually, significantly increasing demand for diagnostic testing.

Technological advancements are another major catalyst for market expansion. Modern innovations including AI-powered diagnostic platforms, liquid biopsy technologies, next-generation sequencing (NGS), automated laboratory systems, and cloud-connected testing devices have significantly improved testing efficiency and accuracy. These technologies enable faster diagnosis while supporting personalized treatment strategies.

The growing adoption of home-based blood testing and remote healthcare services is also expanding market opportunities. Consumers increasingly prefer convenient self-testing solutions that allow sample collection from home while maintaining connectivity with healthcare professionals through telemedicine platforms.

Key Players and Industry Leaders

The competitive landscape of the blood testing market consists of several global diagnostic and healthcare technology companies focused on product innovation, strategic collaborations, and geographic expansion. Major companies operating in the industry include Abbott, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, BIOMÉRIEUX, Quest Diagnostics, Grifols, S.A., Sysmex Corporation, Guardant Health, GRAIL, Inc., Everlywell, Freenome Holdings, Inc., Hologic, Inc., and Trinity Biotech.

These companies continue investing heavily in research and development to introduce advanced diagnostic platforms, improve testing accuracy, and expand blood testing applications across oncology, infectious diseases, cardiovascular disorders, and personalized medicine.

Key Trends for the Future

The future of the blood testing market is being shaped by digital transformation and precision diagnostics. AI-assisted laboratory analysis is enhancing diagnostic accuracy while reducing human error. Point-of-care testing devices continue to gain popularity by enabling rapid diagnosis in emergency departments, clinics, and home settings.

Liquid biopsy technology is revolutionizing cancer diagnostics by enabling non-invasive disease detection using blood samples instead of surgical tissue biopsies. Simultaneously, wearable health technologies, cloud-based laboratory management systems, and remote patient monitoring are creating more connected healthcare ecosystems.

Growing interest in preventive healthcare and personalized medicine is expected to further increase routine blood testing, genetic screening, and biomarker-based diagnostics throughout the forecast period.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/blood-testing-market.html

New Opportunities and Challenges

The blood testing market presents significant growth opportunities through expanding home diagnostics, telehealth integration, emerging biomarkers, and companion diagnostics for targeted therapies. Developing economies also offer substantial untapped potential as governments continue investing in healthcare infrastructure and diagnostic accessibility.

Collaborations among diagnostic manufacturers, healthcare providers, technology companies, and research organizations are expected to accelerate innovation and improve healthcare delivery.

However, the industry continues to face several challenges. High costs associated with advanced diagnostic technologies limit widespread adoption, particularly in low-income regions. Strict regulatory approval processes often delay product commercialization, while shortages of skilled laboratory professionals and concerns regarding testing accuracy remain ongoing obstacles. Limited healthcare infrastructure in developing countries also restricts access to advanced blood testing services.

Market Trends & Innovations

Innovation remains central to the evolution of the blood testing market. Automated laboratory analyzers are improving workflow efficiency by processing large testing volumes with minimal human intervention. AI-powered diagnostic software is supporting clinicians by interpreting complex laboratory data more accurately and rapidly.

Lab-on-a-chip technologies are enabling miniaturized testing platforms that require smaller blood samples while delivering faster results. Molecular diagnostics and next-generation sequencing continue expanding the capabilities of blood testing, particularly for cancer detection and inherited genetic disorders.

Glucose testing remains the largest market segment due to the global burden of diabetes. Continuous glucose monitoring systems, needle-free technologies, and smartphone-connected monitoring devices are improving patient convenience while supporting long-term disease management.

Future Outlook

The global blood testing market is expected to maintain strong growth through 2035, supported by continuous innovation, increasing disease burden, and greater emphasis on preventive healthcare. The expansion of AI-enabled diagnostics, home healthcare solutions, personalized medicine, and digital health platforms will continue transforming blood testing into faster, more accurate, and patient-centric diagnostic services.

North America is expected to retain its market leadership due to advanced healthcare infrastructure, favorable reimbursement policies, high awareness regarding preventive screening, and strong presence of major diagnostic companies. Meanwhile, Asia Pacific is projected to register the fastest growth owing to rapid urbanization, expanding healthcare infrastructure, rising chronic disease prevalence, and increasing government investments in diagnostic services.

Overall, the market outlook remains highly positive as healthcare systems increasingly prioritize early diagnosis, efficient disease monitoring, and accessible diagnostic technologies to improve global health outcomes.

Market Segmentation

By Test Type
• Glucose Testing
• A1C Testing
• Direct LDL Testing
• Lipid Panel Testing
• Prostate Specific Antigen Testing
• COVID-19 Testing
• BUN Testing
• Vitamin D Testing
• Thyroid Stimulating Hormone (TSH) Testing
• Serum Nicotine/Cotinine Testing
• High Sensitivity CRP Testing
• Testosterone Testing
• ALT Testing
• Cortisol Testing
• Creatinine Testing
• AST Testing
• Other Blood Tests

By Method
• Manual Blood Testing
• Automated Blood Testing

By End-user
• Hospitals
• Diagnostic Centers
• Research Laboratories
• Others

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=2517<ype=S

Important FAQs with Answers

1. What was the global blood testing market size in 2024?
The market was valued at US$ 104.4 Bn in 2024.

2. What is the projected market value by 2035?
The market is expected to exceed US$ 249.7 Bn by the end of 2035.

3. What is the expected CAGR during the forecast period?
The market is projected to grow at a CAGR of 8.2% from 2025 to 2035.

4. Which factors are driving market growth?
Major growth drivers include increasing chronic diseases, technological advancements, preventive healthcare, and home-based testing adoption.

5. Which blood testing segment leads the market?
Glucose testing remains the leading segment due to the increasing global prevalence of diabetes.

More Trending Reports by Transparency Market Research -

Adhesive Bandages Market: https://www.transparencymarketresearch.com/adhesive-bandages-market.html

Lipid Disorder Treatment Market: https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html

Proliferative Diabetic Retinopathy Market: https://www.transparencymarketresearch.com/proliferative-diabetic-retinopathy-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com

This release was published on openPR.